Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART). a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

The UK Multiple Sclerosis Society Clinical Trials Network, Peter Connick, Floriana De Angelis, Richard Parker, Domenico Plantone, Anisha Doshi, Nevin John, Jonathan Stutters, David MacManus, Ferran Prados Carrasco, Frederik Barkhof, Sébastien Ourselin, Marie Braisher, Moira Ross, Gina Cranswick, Christopher Weir

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART). a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences